Virtus Health (ASX:VRT) welcomes Victoria's IVF backdown

Company News

by Lauren Evans

Virtus Health (ASX:VRT) welcomes yesterday’s announcement from the Victorian Government after listening to the many people impacted by the suspension of IVF procedures in Victoria.

All IVF treatments and other procedures in NSW, Queensland and internationally are not currently impacted by elective surgery restrictions, while IVF procedures in Victoria can restart. 

“This is tremendous news for women and couples across Victoria who need access to time-critical IVF procedures in order to have a baby,” said chief executive officer of Virtus Kate Munnings.

“We thank our patients for their support, particularly as the restrictions in IVF procedures in Victoria has been so distressing for so many. The support from patients, our staff and the community in highlighting the importance of providing continuous access to fertility services has been remarkable.”

Over the past few weeks Melbourne IVF’s clinics remained open, providing care for patients via fertility specialist video consultations, providing counselling services as well as providing other fertility treatments.

Shares in Virtus Health (ASX:VRT) are trading 0.8 per cent higher at $7.26. 

Are you a 708 sophisticated investor?

A sophisticated investor is defined under Section 708 of the Corporations Act (net assets of $2.5 million or annual incomes in excess of $250,000).

They are eligible to receive information regarding wholesale investment opportunities that are not available to regular or retail investors.

Please subscribe if you would like to be alerted to these types of opportunities.